Search Results - "BRAFMAN, Lois"

Prevalence of Joint Symptoms in Postmenopausal Women Taking Aromatase Inhibitors for Early-Stage Breast Cancer by CREW, Katherine D, GREENLEE, Heather, CAPODICE, Jillian, RAPTIS, George, BRAFMAN, Lois, FUENTES, Deborah, SIERRA, Alex, HERSHMAN, Dawn L

“…Aromatase inhibitors (AIs) improve survival in postmenopausal women with hormone-sensitive breast cancer, but can cause joint pain and stiffness. The purpose…”
Get full text

Randomized, Blinded, Sham-Controlled Trial of Acupuncture for the Management of Aromatase Inhibitor–Associated Joint Symptoms in Women With Early-Stage Breast Cancer by CREW, Katherine D, CAPODICE, Jillian L, GREENLEE, Heather, BRAFMAN, Lois, FUENTES, Deborah, AWAD, Danielle, TSAI, Wei Yann, HERSHMAN, Dawn L

“…PURPOSE Women with breast cancer (BC) treated with aromatase inhibitors (AIs) may experience joint symptoms that can lead to discontinuation of effective…”
Get full text

Zoledronic Acid Prevents Bone Loss in Premenopausal Women Undergoing Adjuvant Chemotherapy for Early-Stage Breast Cancer by HERSHMAN, Dawn L, MCMAHON, Donald J, CREW, Katherine D, CREMERS, Serge, IRANI, Dinaz, CUCCHIARA, Gina, BRAFMAN, Lois, SHANE, Elizabeth

“…Adjuvant chemotherapy for breast cancer (BC) may be associated with increased rates of bone loss and decreased bone mineral density (BMD) and may lead to…”
Get full text

Phase II study of topotecan and paclitaxel for recurrent, persistent, or metastatic cervical carcinoma by Tiersten, Amy D, Selleck, Meredith J, Hershman, Dawn L, Smith, D, Resnik, Edward E, Troxel, Andrea B, Brafman, Lois B, Shriberg, Laureen

“…Objective. This trial investigated the safety and efficacy of paclitaxel and topotecan combination chemotherapy for patients with advanced cervical cancer…”
Get full text

IMPLEMENTATION OF A STANDARDIZED ANTINEOPLASTIC TELEHEALTH EDUCATION WORKFLOW - QUALITY IMPROVEMENT INITIATIVE by Brown, Jessica, Armentano, Francine, Brafman, Lois, Fuentes, Deborah, Wu, Ruby, Accordino, Melissa

“…ASCO-ONS 2016 guidelines specify the necessity of patient antineoplastic education with documentation prior to antineoplastic administration. Advanced Practice…”
Get full text

Association between patient reported outcomes and quantitative sensory tests for measuring long-term neurotoxicity in breast cancer survivors treated with adjuvant paclitaxel chemotherapy by Hershman, Dawn L, Weimer, Louis H, Wang, Antai, Kranwinkel, Grace, Brafman, Lois, Fuentes, Deborah, Awad, Danielle, Crew, Katherine D

“…Neurotoxicity is a common side-effect during taxane therapy. The prevalence and severity of long-term neurotoxicity following therapy is unknown. The authors…”
Get full text

Randomized controlled trial of a clinic-based survivorship intervention following adjuvant therapy in breast cancer survivors by Hershman, Dawn L., Greenlee, Heather, Awad, Danielle, Kalinsky, Kevin, Maurer, Matthew, Kranwinkel, Grace, Brafman, Lois, Jayasena, Ramona, Tsai, Wei-Yann, Neugut, Alfred I., Crew, Katherine D.

“…In 2006, the IOM released a report citing the importance of “survivorship plans” to improve quality of life and care coordination for cancer survivors, but…”
Get full text

A standardized workflow to improve the consent process among patients initiating an oral anticancer drug by Brown, Jessica S., Hershman, Dawn L., O'Neil, Daniel, Brafman, Lois, Fuentes, Deborah A., Graafland, Laura, Law, Cynthia, Trivedi, Meghna S., Kalinsky, Kevin, Crew, Katherine D., Accordino, Melissa Kate

“…Abstract only 259 Background: The American Society of Clinical Oncology and The Oncology Nursing Society’s guidelines recommend that consent be obtained and…”
Get full text

Survivorship care plans and adherence to lifestyle recommendations among breast cancer survivors by Greenlee, Heather, Molmenti, Christine L. Sardo, Crew, Katherine D., Awad, Danielle, Kalinsky, Kevin, Brafman, Lois, Fuentes, Deborah, Shi, Zaixing, Tsai, Wei-Yann, Neugut, Alfred I., Hershman, Dawn L.

“…Purpose The effectiveness of survivorship care plans has not been widely tested. We evaluated whether a one-time brief lifestyle consultation as part of a…”
Get full text

Phase II study of glucosamine with chondroitin on aromatase inhibitor-associated joint symptoms in women with breast cancer by Greenlee, Heather, Crew, Katherine D., Shao, Theresa, Kranwinkel, Grace, Kalinsky, Kevin, Maurer, Matthew, Brafman, Lois, Insel, Beverly, Tsai, Wei Yann, Hershman, Dawn L

“…Purpose Many women with hormone receptor-positive breast cancer discontinue effective aromatase inhibitor (AI) treatment due to joint symptoms. Methods We…”
Get full text

Prevention of Bone Loss by Zoledronic Acid in Premenopausal Women Undergoing Adjuvant Chemotherapy Persist up to One Year following Discontinuing Treatment by Hershman, Dawn L, McMahon, Donald J, Crew, Katherine D, Shao, Theresa, Cremers, Serge, Brafman, Lois, Awad, Danielle, Shane, Elizabeth

“…Context: Adjuvant chemotherapy is associated with significant reductions in bone mineral density (BMD) in premenopausal women with breast cancer (BC) that is…”
Get full text

Abstract C28: Effects of vitamin D supplementation on breast imaging and blood-based biomarkers of breast cancer risk by Sivasubramanian, Parijatham S., Xiao, Tong, Hershman, Dawn L., Maurer, Matthew, Kalinsky, Kevin, Feldman, Sheldon, Brafman, Lois, Refice, Susan, Kranwinkel, Grace, Crew, Katherine D.

“…Background: Vitamin D deficiency is a potentially modifiable risk factor that may be targeted for breast cancer prevention. Observational studies have…”
Get full text

Abstract A48: Pitfalls of using breast magnetic resonance imaging (MRI) in an early-phase breast cancer chemoprevention trial of vitamin D among high-risk postmenopausal women by Reimers, Laura L., Hershman, Dawn L., Maurer, Matthew, Kalinsky, Kevin, Brafman, Lois, Kranwinkel, Grace, Crew, Katherine D.

“…Background: Mammographic density (MD), which refers to the relative proportions of radiodense fibroglandular tissue and radiolucent fat seen on a mammogram, is…”
Get full text

A Phase II trial of docetaxel and estramustine in patients with refractory metastatic breast carcinoma by Tiersten, Amy D., Nelsen, Caron, Talbot, Susan, Vahdat, Linda, Fine, Robert, Troxel, Andrea, Brafman, Lois, Shriberg, Laureen, Antman, Karen, Petrylak, Daniel P.

“…BACKGROUND The similarity between the mechanism of action between docetaxel and estramustine generated the hypothesis of synergistic antimicrotubule effects…”
Get full text